Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1535794

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1535794

Hair Growth Supplement and Treatment Market - By Type, By Distribution Channel - Global Forecast 2024-2032

PUBLISHED:
PAGES: 176 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Hair Growth Supplement and Treatment Market size is poised to record 6.1% CAGR from 2024-2032, due to rising innovations, such as low-level laser therapy (LLLT), microneedling, and platelet-rich plasma (PRP) treatments. These advanced techniques are available in clinics as well as for home-use. With the emerging trend of personalization, companies are offering tailored solutions based on individual hair types, scalp conditions, and specific hair loss issues. The surging interest in natural and organic options in hair care, including ingredients like biotin, collagen, saw palmetto, and botanical extracts will also prove favorable for the market growth.

The hair growth supplement and treatment industry is segmented into type, gender, distribution channel, and region.

The industry value from the female gender segment may witness robust CAGR between 2024 and 2032. The growth can be attributed to the rising need to address unique causes and patterns of hair loss in women. A wide range of products including shampoos, conditioners, and treatments have been designed for female hair loss. The emergence of various topical treatment methods to stimulate hair follicles and promote growth will also support the segment expansion.

By distribution channel, the hair growth supplement and treatment industry from the retail pharmacies segment is expected to expand exponentially through 2032. This is due to the convenience of purchasing hair growth products without the need for prescription or visit to a specialist. These pharmacies offer promotional activities and discounts, making hair growth supplements and treatments more attractive and affordable to consumers. Products sold on these channels also the meet stringent regulatory standards while ensuring safety and efficacy.

Regionally, the Europe hair growth supplement and treatment market size may witness significant CAGR through 2032, propelled by the greater awareness about hair loss issues. With rapid technological advances, laser therapy and scalp treatments have gained popularity in specialized clinics and salons. The growing preference for natural and organic ingredients in hair growth supplements and treatments will also define the regional industry growth.

Product Code: 9725

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing awareness and concern about hair health
      • 3.2.1.2 Rising prevalence of hair disorders
      • 3.2.1.3 Surge in technological advancement and research
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Easy availability of alternative treatments
      • 3.2.2.2 Side effects associated with treatment
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Pricing analysis
    • 3.6.1 Hair supplements
    • 3.6.2 Hair treatment
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Supplements
    • 5.2.1 Powder
    • 5.2.2 Gummies
    • 5.2.3 Tablets
    • 5.2.4 Capsules
    • 5.2.5 Liquid
    • 5.2.6 Other dosage forms
  • 5.3 Pharmaceuticals
    • 5.3.1 Oral
    • 5.3.2 Topical & Injectables
    • 5.3.3 Devices

Chapter 6 Market Estimates and Forecast, By Gender, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Male
  • 6.3 Female

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospital pharmacies
  • 7.3 E-commerce
  • 7.4 Retail pharmacies
  • 7.5 Other distribution channels

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 The Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Hair Supplements
    • 9.1.1 Amway Corporation
    • 9.1.2 GNC Holdings, Inc.
    • 9.1.3 HUM Nutrition
    • 9.1.4 Nature's Bounty
    • 9.1.5 Nutraceutical Wellness, Inc.
    • 9.1.6 OUAI Healthcare
    • 9.1.7 Phyto
    • 9.1.8 Viviscal Limited (Church & Dwight Co., Inc.)
  • 9.2 Hair Treatment
    • 9.2.1 Cipla Limited
    • 9.2.2 Curallux, LLC
    • 9.2.3 Eli Lilly, and Company
    • 9.2.4 ExoCoBio, Inc.
    • 9.2.5 Keranique
    • 9.2.6 Lexington International
    • 9.2.7 Merck & Co., Inc.
    • 9.2.8 Pfizer, Inc.
    • 9.2.9 Rogaine (Johnson & Johnson)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!